Fluicell (Sweden) Performance
| FLUI Stock | SEK 8.50 0.20 2.41% |
The firm shows a Beta (market volatility) of -0.23, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Fluicell are expected to decrease at a much lower rate. During the bear market, Fluicell is likely to outperform the market. At this point, Fluicell AB has a negative expected return of -0.58%. Please make sure to confirm Fluicell's value at risk, skewness, accumulation distribution, as well as the relationship between the potential upside and kurtosis , to decide if Fluicell AB performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Fluicell AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
| Begin Period Cash Flow | 18.8 M | |
| Total Cashflows From Investing Activities | -772 K |
Fluicell |
Fluicell Relative Risk vs. Return Landscape
If you would invest 1,300 in Fluicell AB on November 2, 2025 and sell it today you would lose (450.00) from holding Fluicell AB or give up 34.62% of portfolio value over 90 days. Fluicell AB is generating negative expected returns and assumes 5.4091% volatility on return distribution over the 90 days horizon. Simply put, 48% of stocks are less volatile than Fluicell, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Fluicell Target Price Odds to finish over Current Price
The tendency of Fluicell Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 8.50 | 90 days | 8.50 | roughly 96.0 |
Based on a normal probability distribution, the odds of Fluicell to move above the current price in 90 days from now is roughly 96.0 (This Fluicell AB probability density function shows the probability of Fluicell Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Fluicell AB has a beta of -0.23. This usually indicates as returns on the benchmark increase, returns on holding Fluicell are expected to decrease at a much lower rate. During a bear market, however, Fluicell AB is likely to outperform the market. Additionally Fluicell AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Fluicell Price Density |
| Price |
Predictive Modules for Fluicell
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Fluicell AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Fluicell Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Fluicell is not an exception. The market had few large corrections towards the Fluicell's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Fluicell AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Fluicell within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.55 | |
β | Beta against Dow Jones | -0.23 | |
σ | Overall volatility | 1.44 | |
Ir | Information ratio | -0.12 |
Fluicell Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Fluicell for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Fluicell AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Fluicell AB generated a negative expected return over the last 90 days | |
| Fluicell AB has high historical volatility and very poor performance | |
| Fluicell AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 2.6 M. Net Loss for the year was (21.69 M) with profit before overhead, payroll, taxes, and interest of 1.89 M. | |
| Fluicell AB has accumulated about 20.69 M in cash with (18.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.45. |
Fluicell Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Fluicell Stock often depends not only on the future outlook of the current and potential Fluicell's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Fluicell's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 12 M | |
| Cash And Short Term Investments | 20.7 M |
Fluicell Fundamentals Growth
Fluicell Stock prices reflect investors' perceptions of the future prospects and financial health of Fluicell, and Fluicell fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Fluicell Stock performance.
| Return On Equity | -1.13 | |||
| Return On Asset | -0.49 | |||
| Operating Margin | (8.62) % | |||
| Current Valuation | 49.13 M | |||
| Shares Outstanding | 24.49 M | |||
| Price To Book | 4.86 X | |||
| Price To Sales | 10.51 X | |||
| Revenue | 2.6 M | |||
| EBITDA | (21.08 M) | |||
| Cash And Equivalents | 20.69 M | |||
| Cash Per Share | 1.45 X | |||
| Debt To Equity | 0.19 % | |||
| Book Value Per Share | 0.76 X | |||
| Cash Flow From Operations | (18.64 M) | |||
| Earnings Per Share | (1.68) X | |||
| Total Asset | 26.98 M | |||
About Fluicell Performance
Assessing Fluicell's fundamental ratios provides investors with valuable insights into Fluicell's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Fluicell is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Fluicell AB provides single-cell discovery platforms for biomedicine, drug development, and bioprinting applications worldwide. The company was founded in 2012 and is based in Gothenburg, Sweden. Fluicell operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 17 people.Things to note about Fluicell AB performance evaluation
Checking the ongoing alerts about Fluicell for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Fluicell AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Fluicell AB generated a negative expected return over the last 90 days | |
| Fluicell AB has high historical volatility and very poor performance | |
| Fluicell AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 2.6 M. Net Loss for the year was (21.69 M) with profit before overhead, payroll, taxes, and interest of 1.89 M. | |
| Fluicell AB has accumulated about 20.69 M in cash with (18.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.45. |
- Analyzing Fluicell's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Fluicell's stock is overvalued or undervalued compared to its peers.
- Examining Fluicell's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Fluicell's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Fluicell's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Fluicell's stock. These opinions can provide insight into Fluicell's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Fluicell Stock Analysis
When running Fluicell's price analysis, check to measure Fluicell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fluicell is operating at the current time. Most of Fluicell's value examination focuses on studying past and present price action to predict the probability of Fluicell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fluicell's price. Additionally, you may evaluate how the addition of Fluicell to your portfolios can decrease your overall portfolio volatility.